MULTICENTER VALIDATION OF TECHNICAL PERFORMANCE SCORE AS A QUALITY ASSESSMENT TOOL IN CONGENITAL CARDIAC SURGERY  by Nathan, Meena et al.
Congenital Heart Disease
A483
JACC March 17, 2015
Volume 65, Issue 10S
multiCenter validation of teChniCal performanCe sCore as a Quality assessment 
tool in Congenital CardiaC surgery
Moderated Poster Contributions
Congenital Heart Disease Moderated Poster Theater, Poster Hall B1
Saturday, March 14, 2015, 10:15 a.m.-10:25 a.m.
Session Title: Congenital Heart Disease: Quality & Outcomes
Abstract Category: 11.  Congenital Heart Disease: Pediatric
Presentation Number: 1130M-05
Authors: Meena Nathan, Hua Liu, Steven Colan, Lazaros Kochilas, Geetha Raghuveer, David Overman, Emile Bacha, O Brien James, 
James St Louis, David Kalfa, Brett Anderson, Marko Vezmar, Kimberlee Gauvreau, Kathy Jenkins, Pedro del Nido, Boston Children’s 
Hospital, Boston, MA, USA, University of Minnesota Children’s Hospital, Minneapolis, MN, USA
Background:  Technical Performance Score (TPS), a novel tool for assessing adequacy of repair of congenital cardiac defects based on 
clinical and echocardiographic data, has been validated and correlates with outcomes in single center studies. This study aims to validate 
TPS in a multicenter environment.
methods:  Patients discharged between January 1 and December 31, 2011 from 5 participating centers who underwent Norwood, 
bidirectional Glenn (BDG), Fontan, arterial switch operation (ASO), arch repair /VSD closure (Arch/VSD), complete atrioventricular canal 
(CAVSD) repair, tetralogy of Fallot (TOF) repair, ventricular septal defect (VSD) closure and pulmonary valve replacement (PVR), were 
assigned TPS at each center. Outcomes included postoperative adverse events, length of ventilation and hospital stay, assessed using 
regression techniques.
results:  The 925 discharges included: Norwood 85, BDG 75, Fontan 97, ASO 58, Arch/VSD 58, CAVSD 135, TOF 112, VSD 163 and 
PVR 116. Figure1 shows that Class 3 TPS (major residua or unplanned pre discharge reintervention) had worse outcomes compared to 
Class 1 TPS (trivial or no residua) for all except Arch/VSD. On multivariable modeling after adjusting for age, prematurity, extracardiac 
anomalies, center and cardio-pulmonary bypass time; Class 3 TPS remained associated with adverse outcomes for Norwood, BDG, 
Fontan, ASO, CAVSD and TOF .
Conclusion:  TPS correlates with early outcomes and may serve as a quality assessment tool in congenital heart surgery.
 
